Clinical Trials in Dearborn, United States
Locations / Dearborn, United States
Delta Trials records 741 clinical trials conducted in Dearborn, United States, making it a notable site of clinical research activity. These trials across 1,642 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 68 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Dearborn has changed over time.
741
Total Trials
1642
Conditions
68
Terminated since 2020
Browse by condition (1642 total)
- Breast cancer 54 trialsAll Breast cancer trials
- Lung cancer 31 trialsAll Lung cancer trials
- Diabetes mellitus, type 2 20 trialsAll Diabetes mellitus, type 2 trials
- Prostate cancer 16 trialsAll Prostate cancer trials
- All Unspecified adult solid tumor, protocol specific trials
- Lymphoma 14 trialsAll Lymphoma trials
- Recurrent ovarian carcinoma 13 trialsAll Recurrent ovarian carcinoma trials
- Colorectal cancer 13 trialsAll Colorectal cancer trials
- COVID-19 12 trialsAll COVID-19 trials
- Leukemia 12 trialsAll Leukemia trials
- Recurrent breast carcinoma 12 trialsAll Recurrent breast carcinoma trials
- Type 2 diabetes 12 trialsAll Type 2 diabetes trials
- Pain 11 trialsAll Pain trials
- Recurrent fallopian tube carcinoma 11 trialsAll Recurrent fallopian tube carcinoma trials
- Recurrent primary peritoneal carcinoma 11 trialsAll Recurrent primary peritoneal carcinoma trials
- Coronary artery disease 10 trialsAll Coronary artery disease trials
- Recurrent squamous cell lung carcinoma 10 trialsAll Recurrent squamous cell lung carcinoma trials
- Ovarian endometrioid adenocarcinoma 9 trialsAll Ovarian endometrioid adenocarcinoma trials
- All Stage iv breast cancer ajcc v6 and v7 trials
- Invasive breast carcinoma 9 trialsAll Invasive breast carcinoma trials